Text Messaging to Reduce Alcohol Relapse in Liver Transplant Patients
Completed · Not applicable
Conditions studied: Alcoholic Liver Disease
In brief
This is a research study of a text-messaging intervention to reduce alcohol relapse risk in pre-transplant liver transplantation patients. This study is an 8-week, randomized controlled pilot trial to investigate the feasibility and acceptability of a text-messaging intervention for alcohol relapse prevention and stress reduction in 20 liver transplant patients with alcohol-related liver disease. The goals of the study are (1) to develop a mobile, SMS-based stress reduction and alcohol use intervention for pre- liver transplant patients with alcohol-related liver disease (ALD) and (2) to evaluate the feasibility and acceptability of the mobile intervention and its effect on rates of alcohol consumption compared to a Standard Care condition in a liver transplantation center.
Key facts
- Study ID
- NCT03402256
- Run by
- Yale University
- People needed
- 15
- Starts
- 2013-03-22
- Expected to finish
- 2014-05-06
- Last updated by the study team
- 2018-01-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- at least 18 years of age;
- diagnosis of alcohol-related liver disease;
- currently in evaluation for UNOS listing as a liver transplant candidate;
- last reported use of any alcohol within the past 1 year;
- willingness to receive and respond to multiple text messages per day.
You may not qualify if…
- unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis, or dementia.
Where it is running
- Yale Transplantation Center/Yale-New Haven Hospital — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.